Erlotinib: A kinase inhibitor

Anniepery03 Feb, 2022Health

Healthcare professionals use the drug Erlotinib in treating patients who are suffering from non-small cell lung cancer when tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations and patients with locally advanced, unresectable, or metastatic pancreatic cancer. Erlotinib is a kinase inhibitor. The medicine comprises an active ingredient, Erlotinib hydrochloride, and inactive ingredients; lactose monohydrate, microcrystalline cellulose, hypromellose, hydroxypropyl cellulose, sodium starch glycolate, magnesium stearate, sodium lauryl sulfate, and titanium dioxide. This medicine is supplied in 150 mg and 100 mg tablets for oral administration. Erlotinib 150 mg is readily available in India, and you can find this medication with multiple generic medicine suppliers.